Skip to main content

Microart Inc. (MCRT)

New York Stock Exchange Healthcare BiotechnologyView data quality →
24.5Poor

ValueMarkers Composite Index

Top 0%#44,704 of 44,707

DCF data not available

Piotroski
0/9
Weak
Beneish
-
Altman
-
DCF Value
-
N/A
ROIC
-
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Microart Inc. (MCRT) — VMCI valuation read

Microart Inc. (MCRT) carries a VMCI composite of 25/100, 26 points below the Healthcare sector median of 50. Among mid-cap names, that gap places MCRT in the bottom third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The MCRT insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads MCRT trades at 18.0x earnings, 0% above the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 18.0% sits 8.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of 2.9x is the rate-sensitivity line to watch, the line to track on Microart Inc.'s next 10-Q.

MCRT fell 1.9% over the trailing 7 days, with a -11.6% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in MCRT’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.